XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Common Stock
RSUs
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2021   102,484        
Beginning balance at Jan. 31, 2021 $ 431,412 $ 10   $ 829,238 $ (45) $ (397,791)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares)   2,848        
Issuance of common stock upon exercise of stock options 8,019 $ 1   8,018    
Exercise of common stock warrants (in shares)   18        
Vesting of restricted stock units (in shares)     842      
Vesting of early exercised stock options 49     49    
Stock-based compensation 12,133     12,133    
Other comprehensive loss (45)       (45)  
Net loss (26,914)         (26,914)
Ending balance (in shares) at Apr. 30, 2021   106,192        
Ending balance at Apr. 30, 2021 424,654 $ 11   849,438 (90) (424,705)
Beginning balance (in shares) at Jan. 31, 2022   113,813        
Beginning balance at Jan. 31, 2022 418,969 $ 11   944,447 (4,333) (521,156)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares)   1,341        
Issuance of common stock upon exercise of stock options 6,954 $ 1   6,953    
Vesting of restricted stock units (in shares)     492      
Vesting of early exercised stock options 33     33    
Stock-based compensation 13,328     13,328    
Other comprehensive loss (3,537)       (3,537)  
Net loss (34,750)         (34,750)
Ending balance (in shares) at Apr. 30, 2022   115,646        
Ending balance at Apr. 30, 2022 $ 400,997 $ 12   $ 964,761 $ (7,870) $ (555,906)